Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.
❓ Unknown
New Gene Linked to Blood Cancer Drug Resistance Discovered Using CRISPR Technology
Just now
September 18, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Researchers have identified a new gene responsible for resistance to a major blood cancer treatment and additional genes that promote lymphoma growth using an advanced CRISPR activation tool. This discovery could have implications for cancer treatment strategies globally, including in Iran. Understanding drug resistance is crucial for improving healthcare outcomes.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
13 min ago •
Warren Buffett Transfers Chairmanship of Berkshire Hathaway to His Son
20 min ago •
AI System Enhances Rehabilitation Exercises on Low-Powered Devices
20 min ago •
How a single viral protein hijacks immune cells to supercharge COVID-19 infection
20 min ago •
Engineered Thermal Insulator Surpasses Natural Materials in Performance
20 min ago •